Granules India Ltd (GRAN)

Currency in INR
439.55
-10.45(-2.32%)
Closed·
GRAN Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
GRAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
438.30454.40
52 wk Range
422.00721.00
Key Statistics
Bid/Ask
439.30 / 439.60
Prev. Close
450
Open
452
Day's Range
438.3-454.4
52 wk Range
422-721
Volume
825.37K
Average Volume (3m)
1.04M
1-Year Change
-32.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Granules India Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Granules India Ltd Company Profile

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
4066
Market
India

Compare GRAN to Peers and Sector

Metrics to compare
GRAN
Peers
Sector
Relationship
P/E Ratio
21.3x27.6x−0.5x
PEG Ratio
0.910.640.00
Price/Book
2.9x3.4x2.6x
Price / LTM Sales
2.4x4.4x3.3x
Upside (Analyst Target)
36.0%14.3%43.5%
Fair Value Upside
Unlock−0.1%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 20.69%
Dividend Yield
0.34%
Industry Median 0.73%
Annualised payout
1.50
Paid unevenly
5-Years Growth
+8.45%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
5.15 / 7.00
Revenue / Forecast
11.97B / 11.32B
EPS Revisions
Last 90 days

GRAN Income Statement

People Also Watch

384.60
BAJE
-0.81%
2,019.60
GLEN
-2.09%
3,144.20
MAHM
-2.08%
821.85
LAUL
-1.96%
495.95
VARB
-1.34%

FAQ

What Stock Exchange Does Granules India Trade On?

Granules India is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Granules India?

The stock symbol for Granules India is "GRAN."

What Is the Granules India Market Cap?

As of today, Granules India market cap is 106.68B.

What Is Granules India's Earnings Per Share (TTM)?

The Granules India EPS (TTM) is 20.69.

When Is the Next Granules India Earnings Date?

Granules India will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is GRAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Granules India Stock Split?

Granules India has split 1 times.

How Many Employees Does Granules India Have?

Granules India has 4066 employees.

What is the current trading status of Granules India (GRAN)?

As of 09 Aug 2025, Granules India (GRAN) is trading at a price of 439.55, with a previous close of 450.00. The stock has fluctuated within a day range of 438.30 to 454.40, while its 52-week range spans from 422.00 to 721.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.